Skip to main content

Table 2 Percent antibiotic susceptibility of E. coli, and Klebsiella spp. during 2015/2016 compared to corresponding susceptibility results in 2011/2013a

From: A compilation of antimicrobial susceptibility data from a network of 13 Lebanese hospitals reflecting the national situation during 2015–2016

Antibiotic

E. coli

Klebsiella spp

2011/2013 N (%S)

2015/2016 N (%S)

OR (95%CI)

P

2011/2013 N (%S)

2015/2016 N (%S)

OR (95% CI)

P

Amikacin

29,667 (97%)

41,818 (90%)

0.29 (0.26–0.3)

0.0001

7768 (96%)

9498 (94%)

0.65 (0.57–0.75)

0.0001

Amoxicillin/clavulanic acid

30,411 (61%)

39,116 (59%)

1.13 (1.10–1.17)

0.0001

7883 (67%)

9069 (62%)

0.80 (0.75–0.86)

0.0001

Ampicillin

22,985 (23%)

35,906 (24%)

1.06 (1.02–1.10)

0.01

Aztreonam

27,221 (66%)

40,029 (57%)

0.65 (0.63–0.67)

0.0001

7020 (69%)

7924 (65%)

0.83 (0.78–0.90)

0.0001

Cefepime

26,314 (74%)

40,524 (62%)

0.60 (0.58–0.62)

0.0001

Cefoxitin

23,858 (87%)

33,104 (76%)

0.47 (0.45–0.50)

0.0001

5853 (89%)

6373 (83%)

0.60 (0.54–0.67)

0.0001

Ceftazidime

28,730 (71%)

41,816 (62%)

0.73 (0.71–0.76)

0.0001

7335 (71%)

9498 (64%)

0.73 (0.68–0.78)

0.0001

Ceftriaxone

20,059 (64%)

41,816 (58%)

0.85 (0.82–0.88)

0.0001

4750 (65%)

9498 (63%)

0.92 (0.85–0.99)

0.02

Cefuroxime

24,662 (59%)

33,106 (56%)

0.96 (0.93–0.99)

0.02

6516 (64%)

6579 (61%)

0.88 (0.82–0.94)

0.0004

Ciprofloxacin

29,411 (55%)

40,524 (57%)

1.22 (1.19–1.26)

0.0001

7883 (73%)

9311 (71%)

0.91 (0.85–0.97)

0.004

Gentamicin

29,327 (72%)

41,818 (72%)

1.00 (0.98–1.03)

1

7601 (75%)

9498 (78%)

1.18 (1.10–1.27)

0.0001

Imipenem

30,411 (99%)

41,813 (97%)

0.33 (0.29–0.37)

0.0001

7883 (98%)

9498 (96%)

0.49 (0.41–0.60)

0.0001

Nitrofurantoin

18,422 (96%)

29,434 (87%)

0.28 (0.26–0.30)

0.0001

4356 (52%)

5155 (59%)

1.33 (1.22–1.44)

0.0001

Piperacillin/tazobactam

28,739 (83%)

40,524 (76%)

0.84 (0.81–0.873)

0.0001

7618 (81%)

9292 (78%)

0.83 (0.77–0.90)

0.0001

Tigecycline

9716 (98%)

39,050 (96%)

0.24 (0.20–0.30)

0.0001

2243 (87%)

8546 (93%)

1.99 (1.71–2.31)

0.0001

Trimethoprim/sulfamethoxazole

29,689 (49%)

41,496 (53%)

1.13 (1.10–1.16)

0.0001

7709 (57%)

9498 (58%)

1.04 (0.98–1.11)

0.2

  1. KEY = CI confidence interval, N Number of isolates tested in each bacteria/antibiotic combination, OR Odds Ratio, S Susceptibility, % percent
  2. P < 0.05 is considered statistically significant
  3. aThe 2011/2013 data are taken from: Chamoun K, Farah M, Araj G, et al. Surveillance of antimicrobial resistance in Lebanese hospitals: retrospective nationwide compiled data. Int J Infect Dis. 2016;46:64–70